📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

RAYLAPharmaceuticals

Raymed Labs Ltd — Financial Ratios & Key Metrics

₹3.83

+0.00%

P/E RatioN/AxIndustry: 31.77x

ROEN/AReturn on equity

ROCEN/AReturn on capital

Debt/EquityN/ADebt free ✓

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹1.64 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

N/A

📉

Price Returns

1 Month

+4.93%

3 Months

+4.93%

6 Months

+15.36%

1 Year

+39.27%

52W Low

₹3

Current

₹4

52W High

₹4

100% of 52-week range — Near highs

🔬

Technical Indicators

Overbought

Momentum is strong — price may be stretched. Watch for pullbacks.

SMA 50

₹4

▲ Price above SMA 50 — Bullish

SMA 200

₹3

▲ Long-term uptrend

Technical indicators are for educational purposes only. Not investment advice.

More on Raymed Labs Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.